NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Terrestrial Bio

Terrestrial Bio

Private
Woburn, MassachusettsHealthcare & Life Scienceshttps://www.terrestrialbio.com/

Last Round

Series C

Mar 26, 2026

Total Funding Raised

$86.95M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Terrestrial Bio is a biotechnology company developing a proprietary microarray patch (MAP) platform for the needle-free, temperature-stable self-administration of therapeutics, including GLP-1 medicines.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

microarray patchMAPneedle-free injectiondrug delivery platformbiologics deliveryself-administrationGLP-1 deliverytemperature-stablepatch-based deliverydissolvable microneedlesmicroneedle patchbiotech licensingpatient adherencecold chain freepain-free injection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Terrestrial Bio Comps

Public and private peers based on sector, stage, and business model.

Terrestrial Bio comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Terrestrial Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 26, 2026
VC RoundApr 9, 2025
SeedFeb 12, 2025
SeedFeb 12, 2025
VC RoundMay 22, 2024
Series A
Jun 28, 2019

Terrestrial Bio Investors

Notable investors and investment history

Terrestrial Bio investors
InvestorRounds
Magnetic VenturesSeed
RA Capital ManagementVC Round, Series C
Engine VenturesVC Round, Series C, Series A
SiteGround CapitalSeries C
Massachusetts Life Sciences CenterDebt
Bill & Melinda Gates FoundationGrant
Norwich VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2026

    $50M Series C round completed.

Terrestrial Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Terrestrial Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Terrestrial Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersWoburn, Massachusetts
Year Founded2012
Last FundingMar 26, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.